EUVIMEDEUVIMED entdecken
Open Access

Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma

Ryan M Carey, Vincent J Anagnos, Aman Prasad, Neel R Sangal, Karthik Rajasekaran, Rabie M Shanti, Steven B Cannady, Jason G Newman, Jason A Brant, Robert M Brody

ORL · 2023

DOI: 10.1159/000534491 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ORL, 2023. Verfasst von Ryan M Carey und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Management of the neck in oral cavity squamous cell carcinoma (OCSCC) is essential to oncologic control and survival. The rates of lymph node metastasis (LNM) vary based on oral cavity tumor site and stage and influence treatment decisions. The aim of this paper was to describe clinical LNM for different tumor subsites and stages of surgically managed OCSCC.

Methods

We conducted a retrospective analysis of 25,846 surgically managed OCSCC patients from the National Cancer Database (NCDB) stratified by tumor subsite and clinical T-stage. For cN + patients, rates of pathologic LNM and absence of pathologic LNM were determined. For cN0 patients, outcomes included the rates of elective neck dissection (END) and occult LNM and predictors of occult LNM determined by a multivariable logistic regression model.

Results

A total of 25,846 patients (59.1% male, mean age 61.9 years) met inclusion criteria with primary tumor sites including oral tongue (50.8%), floor of mouth (21.2%), lower alveolus (7.6%), buccal mucosa (6.7%), retromolar area (4.9%), upper alveolus (3.6%), hard palate (2.7%), and mucosal lip (2.5%). Among all sites, clinical N+ rates increased with T-stage (8.9% T1, 28.0% T2, 51.6% T3, 52.5% T4); these trends were preserved across subsites. Among patients with cN + disease, the overall rate of concordant positive pathologic LNM was 80.1% and the rate of discordant negative pathologic LNM was 19.6%, which varied based on tumor site and stage. In the overall cohort of cN0 patients, 59.9% received END, and the percentage of patients receiving END increased with higher tumor stage. Occult LNM among those cN0 was found in 25.1% of END cases, with the highest rates in retromolar (28.8%) and oral tongue (27.5%) tumors. Multivariable regression demonstrated significantly increased rates of occult LNM for higher T stage (T2 OR: 2.1 [1.9–2.4]; T3 OR: 3.0 [2.5–3.7]; T4 OR: 2.7 [2.2–3.2]), positive margins (OR: 1.4 [1.2–1.7]), and positive lymphovascular invasion (OR: 5.1 [4.4–5.8]).

Conclusions

Management of the neck in OCSCC should be tailored based on primary tumor factors and considered for early-stage tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCarcinoma, Squamous CellHead and Neck NeoplasmsHumansMaleMiddle AgedFemaleSquamous Cell Carcinoma of Head and NeckRetrospective StudiesNeoplasm StagingNeck DissectionLymphatic Metastasis

Stichwörter der Autor:innen

Head and neckMetastasisNeck dissectionOral cavitySquamous cell carcinoma

Autor:innen und Institutionen

  • Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA, aman.prasad@pennmedicine.upenn.edu.
  • Department of Oral and Maxillofacial Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.

Zitieren

APA

Carey, R. M., Anagnos, V. J., Prasad, A., Sangal, N. R., Rajasekaran, K., Shanti, R. M., Cannady, S. B., Newman, J. G., Brant, J. A., & Brody, R. M. (2023). Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma. ORL. https://doi.org/10.1159/000534491

Vancouver

Carey RM, Anagnos VJ, Prasad A, Sangal NR, Rajasekaran K, Shanti RM, et al. Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma. ORL. 2023. doi:10.1159/000534491

BibTeX
@article{Carey2023,
  author = {Carey, Ryan M and Anagnos, Vincent J and Prasad, Aman and Sangal, Neel R and Rajasekaran, Karthik and Shanti, Rabie M and Cannady, Steven B and Newman, Jason G and Brant, Jason A and Brody, Robert M},
  title = {Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma},
  journal = {ORL},
  year = {2023},
  doi = {10.1159/000534491}
}
Kostenlos starten →